巴塞罗那地区妊娠早期普遍巨细胞病毒筛查:多中心观察性队列研究
研究认为在公共卫生体系开展早孕期普遍CMV筛查可行且接受度高。
要点
- 早孕期普遍CMV筛查接受度高,可在公共卫生体系中实施。
- 孕妇CMV血清阳性率为77.7%,约22%为易感的血清阴性人群。
- 原发感染率低,早期识别血清阴性者有助于预防咨询和随访。
核心结论
- 在公共卫生体系中,妊娠早期普遍进行CMV筛查是可行的,且孕妇接受度高。
研究设计与样本
- 研究类型为前瞻性多中心观察性队列研究。
- 研究地点包括巴塞罗那及其都市区的4个初级保健中心和2家三级医院。
- 所有参与者在首次产检时接受CMV IgG和IgM血清学检测。
主要发现
- CMV血清阳性率为77.7%(95%CI 76.2%–79.1%),743名孕妇为血清阴性(22.1%,95%CI 20.7%–23.6%)。
- 共识别5例原发CMV感染,比例为0.15%(95%CI 0.05%–0.37%),均接受治疗。
- 羊膜腔穿刺未检出胎儿感染,1名新生儿CMV检测阳性,但出生时及6个月时均无症状。
- 血清阴性女性总体年龄更大、更多为欧洲裔,且教育水平和就业率更高。
关键数值与推荐
- 原发CMV感染诊断标准为IgM阳性且IgG亲和力为低或中等。
- 诊断为原发CMV感染的孕妇根据当地方案接受伐昔洛韦治疗并进行胎儿随访。
- CMV血清阳性率为77.7%(95%CI 76.2%–79.1%),血清阴性率为22.1%(95%CI 20.7%–23.6%)。
- 原发CMV感染率为0.15%(95%CI 0.05%–0.37%)。
临床怎么用
- 可在早孕期首次产检时对孕妇进行CMV IgG和IgM普遍筛查。
- 对IgM阳性且IgG亲和力低的孕妇按原发感染处理,可采用伐昔洛韦治疗并安排胎儿随访。
- 对血清阴性孕妇可提供预防咨询,并在后续妊娠过程中进行针对性随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the CMV seroprevalence among pregnant women and assess the rate of primary CMV infections during the first trimester. DESIGN: Prospective multicentre observational cohort study. SETTING: Four primary care centres (ASSIRs) and two tertiary hospitals in Barcelona and its metropolitan area. PUPULATION OR SAMPLE: Pregnant women attending first-trimester antenatal visits between October 2022 and September 2024. METHODS: All participants underwent CMV IgG and IgM serological testing at the first antenatal visit. Women with positive IgM and low or intermediate IgG avidity were diagnosed with primary CMV infection and managed according to local protocols, including treatment with valaciclovir and fetal follow-up. MAIN OUTCOME MEASURES: CMV screening acceptance rate, seroprevalence, rate of primary infection, fetal infection, and neonatal outcomes up to one year of age. RESULTS: Of 3 677 pregnant women recruited, 3 357 were included in the final analysis. CMV screening acceptance was high. Seroprevalence was 77.7% (95% CI 76.2%-79.1%), and 743 women (22.1%, 95% CI 20.7%-23.6%) were seronegative. Five cases (0.15%, 95% CI 0.05%-0.37%) of primary CMV infection were identified and treated. No fetal infections were detected by amniocentesis. One newborn tested positive for CMV but remained asymptomatic at birth and at 6 months. Women who were seronegative were generally older, of European origin, and had higher education and employment rates. CONCLUSIONS: Universal first-trimester CMV screening is feasible and well accepted in a public healthcare setting. While the rate of primary infection was low, early identification of seronegative women offers opportunities for preventive counselling and targeted follow-up.
引用
- Sánchez-Durán, Esperalba, Scazzocchio, et al. Universal Cytomegalovirus Screening in the First Trimester of Pregnancy: The Multicentre Observational Cohort Study in the Area of Barcelona (CITEMB Study). BJOG. 2026. PMID: 41517885. doi:10.1111/1471-0528.70137
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。